Table 2.

Correlation of the MAF precursor activity of colorectal cancer patients with their serum α-N-acetylgalactosaminidase activity

Patient no.	Time assay week	Precursor activity superoxide (nmol)	NaGalase (nmol/min/mg)
1	0	1.88	2.72
	1	2.01	2.43
	2	2.15	2.02
	3	2.21	1.89
	4	2.75	1.55
	8	3.14	1.15
	11	3.18	1.03
	14	3.20	1.01
	17	3.21	0.99
	20	3.25	0.97
	26	3.45	0.82
	35	4.08	0.68
2	0	2.01	2.56
	4	2.08	2.41
	6	2.25	2.36
	8	2.31	2.28
	9	2.42	1.97
	10	2.51	1.85
	11	2.91	1.62
	15	3.21	1.47
	19	3.69	1.03
	25	3.80	0.88
	36	3.93	0.80
	41	4.01	0.53
	45	4.11	0.44
3	0	0.84	4.84
	1	1.18	4.48
	3	1.24	4.02
	4	1.33	3.77
	6	1.44	3.42
	7	2.12	3.38
	10	2.22	3.02
	16	2.31	2.38
	25	2.44	1.92
	32	2.55	1.75
	40	3.98	0.99
	46	4.01	0.62
	65	4.21	0.40
4	0	0.72	6.71
	1	1.06	5.48
	2	1.31	4.92
	4	1.34	4.82
	6	1.35	4.77
	8	1.37	4.68
	11	1.34	4.40
	16	1.41	4.09
	19	1.49	3.86
	23	1.52	3.32
	27	1.55	3.68
	30	2.11	2.34
	34	2.34	1.76
	43	3.10	1.25
	52	3.62	0.63
	64	3.83	0.50
5	0	2.29	1.78
	1	2.41	1.62
	2	2.40	1.55
	5	3.21	1.33
	9	3.32	0.85
	13	3.42	0.78
	15	3.81	0.66
	25	4.29	0.55